Millennium Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-102,606
| Closed | -$327K | – | 7897 |
|
|
2022
Q2 | $327K | Sell |
102,606
-36,283
| -26% | -$141K | ﹤0.01% | 5294 |
|
|
2022
Q1 | $593K | Sell |
138,889
-612
| -0.4% | -$2.67K | ﹤0.01% | 4994 |
|
|
2021
Q4 | $649K | Sell |
139,501
-510
| -0.4% | -$2.13K | ﹤0.01% | 4813 |
|
|
2021
Q3 | $559K | Sell |
140,011
-261,808
| -65% | -$1.04M | ﹤0.01% | 5248 |
|
|
2021
Q2 | $1.72M | Buy |
401,819
+225,983
| +129% | +$968K | ﹤0.01% | 4144 |
|
|
2021
Q1 | $746K | Buy |
+175,836
| New | +$969K | ﹤0.01% | 4480 |
|
|
2019
Q4 | – | Sell |
-327,057
| Closed | -$2.88M | – | 4926 |
|
|
2019
Q3 | $2.88M | Sell |
327,057
-725,831
| -69% | -$6.86M | ﹤0.01% | 2205 |
|
|
2019
Q2 | $9.74M | Sell |
1,052,888
-415
| -0% | -$3.13K | 0.01% | 1277 |
|
|
2019
Q1 | $6.77M | Buy |
1,053,303
+563,030
| +115% | +$3.67M | 0.01% | 1547 |
|
|
2018
Q4 | $4.62M | Buy |
+490,273
| New | +$7.38M | 0.01% | 1639 |
|
|
2018
Q1 | – | Sell |
-9,214
| Closed | -$297K | – | 4414 |
|
|
2017
Q4 | $297K | Sell |
9,214
-7,926
| -46% | -$259K | ﹤0.01% | 3357 |
|
|
2017
Q3 | $596K | Buy |
+17,140
| New | +$551K | ﹤0.01% | 2760 |
|
|
2017
Q1 | – | Sell |
-38,828
| Closed | -$681K | – | 4178 |
|
|
2016
Q4 | $681K | Buy |
+38,828
| New | +$744K | ﹤0.01% | 2485 |
|
|
2016
Q2 | – | Sell |
-22,202
| Closed | -$464K | – | 3984 |
|
|
2016
Q1 | $464K | Buy |
+22,202
| New | +$396K | ﹤0.01% | 2559 |
|
Millennium Management's LJPC Position: Q3 2022 in Review
Millennium Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 102,606 shares — an estimated $327K sold.
Millennium Management first reported a position in LJPC in Q1 2016 and held it in 14 quarters. The position peaked at $9.74M in Q2 2019. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Millennium Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Millennium Management sold 102,606 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $327K.
- Millennium Management first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 14 quarters.
- Millennium Management's La Jolla Pharmaceutical Company position peaked at $9.74M in Q2 2019.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.